Thomas Grima Email & Phone Number

Swieqi, Mt

Swieqi, Malta

As founder of M&C Consulting and Supplies I spearheaded the import, distribution, and marketing efforts for a diverse range of innovative products, including supplements, adaptogens, beauty, and aesthetic items. With a keen focus on promoting regenerative and environmentally friendly products, I led initiatives to source and promote goods that aligned with our commitment to sustainability and ecological stewardship.Key Accomplishments:Product Sourcing Excellence: Leveraging my expertise in market analysis and industry trends, I successfully identified and sourced novel products from global markets that met our stringent criteria for environmental responsibility and regenerative practices. Through strategic partnerships and diligent supplier relationships, I ensured a steady supply of high-quality, eco-friendly products for our customers.Consumer Education and Engagement: Recognizing the importance of consumer education, I spearheaded initiatives to educate our customer base about the importance of choosing products that prioritize environmental sustainability and regeneration. By fostering transparent communication and providing informative resources, we empowered consumers to make informed purchasing decisions aligned with their values.Compliance and Regulatory Adherence: Ensuring compliance with regulatory requirements and industry standards was paramount in our operations. I proactively stayed abreast of evolving regulations governing the import, distribution, and marketing of consumer products, ensuring full compliance and mitigating any potential risks to our business.My experience in import, distribution, and marketing within the wellness and beauty sectors, coupled with my passion for sustainability, positions me as a valuable asset to any organization committed to making a positive impact on both individuals and the planet.

Żebbuġ, Malta

As a Sales and Marketing Affiliate Partner at MeditPharma, I played a pivotal role in driving business growth and enhancing customer satisfaction within the aesthetic industry. Leveraging my expertise in sales and marketing, I facilitated the acquisition of 10 new clients for the company, expanding our client base and revenue streams.In addition to client acquisition, I focused on boosting sales performance and elevating the standard of customer care. Through strategic marketing initiatives and personalized engagement strategies, I fostered lasting relationships with clients, resulting in increased sales and improved customer loyalty.My role also afforded me the opportunity to network with key players in the aesthetic industry.Overall, my tenure as a Sales and Marketing Affiliate Partner at MeditPharma was characterized by tangible results and impactful contributions to the company's success. Through my dedication, strategic approach, and industry connections, I played an integral role in driving business growth, enhancing sales performance, and solidifying MeditPharma's position as a leader in the aesthetic industry.

As a Medical Representative, I had the privilege to represent and promote Clonmel generics to doctors and pharmacies across Malta, driving sales and fostering strong relationships within the medical community. Additionally, I served as the sole medical representative for medical cannabis brands at Pharma.MT, including Bedrocan, Bediol, WEECO 1A, and Formula Swiss CBD oils, playing a pivotal role in their market penetration and growth.My responsibilities encompassed a wide array of tasks akin to a brand manager, including monitoring market trends, gathering critical feedback for directors, and devising effective marketing strategies. I actively engaged with healthcare professionals, pharmacies, and wholesalers to promote products, take orders, and ensure optimal market presence.My role extended beyond traditional sales duties to encompass strategic planning, event coordination, and marketing material development. Utilizing analytical skills, I maintained comprehensive spreadsheets with competitor data, conducted sales analysis, monitored stock levels, and forecasted future sales trends.Through my efforts, I significantly contributed to the growth of Clonmel generics, elevating monthly net sales from 15-20k to 55-65k. Similarly, I spearheaded the introduction of medical cannabis brands to the market, achieving remarkable success by increasing monthly sales from 0 to over 100k.My tenure at Pharma.MT was characterized by transformative results and a commitment to excellence. By leveraging market insights, fostering relationships, and implementing strategic initiatives, I played a key role in driving sales growth and establishing Pharma.MT as a trusted provider of pharmaceutical products in Malta.

Mosta

Milton, Oxfordshire, United Kingdom

Oncolytic immunotherapy is an emerging class of cancer therapeutics which exploit the ability of viruses to selectively replicate in and kill tumor tissue, while at the same time inducing a potent, patient-specific, anti-tumor immune response. Oncolytic viruses have the unique ability to generate an autologous immune response to the patient’s particular complement of tumor antigens, including neoantigens, with a truly off-the-shelf approach.While clear single agent clinical activity has been achieved with oncolytic immunotherapy, it is anticipated that particular synergy may be observed in combination with immune checkpoint blockade and other immune-modulatory approaches. Immune checkpoint blockade relies on a pre-existing inflamed tumor microenvironment and a pre-existing immune response to tumor neoantigens for clinical activity, which are only present in some patients. Oncolytic immunotherapy can provide both of these and therefore combination of these two proven modalities is particularly logical and attractive.Replimune is developing novel, proprietary oncolytic immunotherapies intended to improve both the direct anti-tumor effects of selective virus replication and the potency of the immune response to the tumor antigens released. Replimune intends to progress these rapidly through clinical trials and to combine these with checkpoint blockade at an early stage of clinical development.

51 Chenies Mews

As a GMP Technician at the Wolfson Gene Therapy Unit (WGTU), I played an integral role in the small-scale manufacture of viral vectors for Phase 1 and Phase 2 gene therapy clinical trials, adhering to the highest standards of Good Manufacturing Practice (GMP) within the guidelines of EudraLex – Volume 4.My primary responsibility involved the production of an ophthalmology gene therapy product for the treatment of Leber congenital amaurosis, ensuring strict adherence to GMP principles throughout the manufacturing process. As part of the production team, I was co-responsible for both upstream and downstream processes essential for the production of gene therapy products.A significant aspect of my role included actively participating in the optimization of the unit's Standard Operating Procedures (SOPs) to achieve full compliance with GMP standards. This entailed raising Quality Incident Reports to initiate change controls for the amendment of non-compliant SOPs. Additionally, I contributed to SOP re-validation efforts to ensure repeatability and consistency in production processes.My involvement in the production process was comprehensive, encompassing various laboratory-based tasks. This included cell culture, transfection with plasmids, treatment with benzonase, cell rupture using microfluidization, AKTA chromatography purification for virus elution, concentration and diafiltration using a TFF module, and sterile vialing of the product in preparation for clinical trials.Through my hands-on involvement from start to finish in the production of gene therapy products, I developed invaluable skills and expertise in GMP-compliant manufacturing processes. My role at the WGTU allowed me to contribute directly to cutting-edge research in gene therapy, ultimately advancing the development of potential treatments for devastating genetic diseases.

London, United Kingdom

In my role as a Production Scientist at RMS, I played a pivotal role in manufacturing cell culture products to the highest GMP standards .Central to my responsibilities was the meticulous manufacturing process of cell culture products, with a focus on autologous cartilage biopsy samples. This involved receiving biopsy samples, enzymatically digesting them, and amplifying cartilage cells up to Passage 6 (P6), culminating in the combination of cells with fibrin glue for subsequent re-implantation procedures.All cell culture activities were meticulously executed within a grade B cleanroom environment, utilizing grade A biosafety cabinets to ensure the utmost sterility and product quality. Throughout my tenure at RMS, I honed my aseptic technique and conducted laboratory activities with precision and adherence to Good Laboratory Practices (GLP).Beyond laboratory duties, I actively contributed to maintaining regulatory compliance by raising change controls as needed and editing Standard Operating Procedure (SOP) documents to align with GMP standards. Additionally, I managed stock levels, conducted environmental monitoring checks, and oversaw the day-to-day operations of cleanroom areas, ensuring seamless production workflows.Working within a small team environment provided invaluable opportunities to develop strong communication skills and experience the benefits of effective collaboration. By fostering a culture of teamwork and mutual support, we optimized productivity and consistently met production targets while upholding the highest quality standards.My tenure as a Production Scientist at RMS was characterized by a relentless commitment to excellence, regulatory compliance, and collaborative teamwork. Through meticulous attention to detail, adherence to GMP standards, and effective communication, I played a key role in manufacturing cell culture products critical to advancing regenerative medicine and improving patient outcomes.

As a full-time student at the University College of London pursuing my master's degree, I immersed myself in advanced studies and practical applications within the field of tissue engineering. Throughout my academic journey, I acquired a diverse skill set and comprehensive knowledge in cutting-edge techniques and methodologies.My coursework provided me with a deep understanding of current tissue engineering techniques, including bioelectrospraying and co-axial electrospinning, which are instrumental in fabricating complex biological structures. I also gained proficiency in 3D printing techniques and 3D cell culture methodologies, exploring various biomaterials and imaging methods to further my understanding of tissue engineering principles.For my thesis project, I delved into the realm of computational modeling using the finite element analysis software, Comsol Multiphysics. Focusing on hepatic bioreactors, I developed a simulation to investigate the potential application of ultrasound radiation forces in fabricating hepatic lobule-like patterns within biological cells. This research aimed to explore innovative approaches to tissue engineering and test the hypothesis that ultrasound radiation forces could be harnessed to create complex cellular structures mimicking natural tissue organization.My academic pursuits at the University College of London not only expanded my theoretical knowledge but also honed my practical skills in experimental design, data analysis, and scientific research. Through rigorous academic inquiry and hands-on experience, I developed a passion for pushing the boundaries of tissue engineering and contributing to advancements in regenerative medicine.

Msc Biomaterials & Tissue Engineering, Ultrasonics

Bsc (Hons), Biomedical Sciences, General, 2:1 Upper

Activities and Societies: Life sciences society, iBEST • Fifty per cent of the course was based on preparing journal like write ups based.